Home
Cormorant Asset Management reported a 5.01% stake in ADS shares of AgomAb Therapeutics AGMB · 2,465,348 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.01%
- Last report
- First report
- Shares held
- 2,465,348 sh
- Class
- American Depositary Shares, each representing one common share, no nominal value per share
- Event date
- 26/03/31
- Filed
- 26/05/15
First 5%+ report · 5.01% stake
AgomAb Therapeutics trades, last 26 weeks
What else happened in AgomAb Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Cormorant Asset Management's other 5% stake reports
- Cormorant Asset Management
5% stakeRallybio
5% stakeRallybio
RLYB
0% stake
0 sh
0% stake
Filed 08/14
- Cormorant Asset Management
5% stakeQuince Therapeutics
5% stakeQuince Therapeutics
QNCX
9.99% stake
108,029 sh
9.99% stake
Filed 08/14
- Cormorant Asset Management
5% stakeMoonLake Immunotherapeutics
5% stakeMoonLake Immunotherapeutics
MLTX
4.35% stake
3,205,433 sh
4.35% stake
Filed 08/14
- Cormorant Asset Management
5% stakeEyePoint
5% stakeEyePoint
EYPT
8.35% stake
7,000,000 sh
8.35% stake
Filed 08/14
- Cormorant Asset Management
5% stakeCabaletta Bio
5% stakeCabaletta Bio
CABA
5.95% stake
10,000,000 sh
5.95% stake
Filed 08/14
